Overview

Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN)

Status:
Withdrawn
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The objective of this project is to determine how pulmonary vascular remodeling in Pulmonary Arterial Hypertension (PAH) at cellular and pathological level is associated with gas exchange physiology changes and hemodynamics (monitored with 129Xe MRI/MRS) and how these signals change with disease progression or treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Bastiaan Driehuys
Collaborator:
Regeneron Pharmaceuticals